Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one ...

A breakthrough in treating insulin-resistant disorders such as type 2 diabetes has been discovered inside the Olefsky lab at ...

Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. While TZDs were extremely popular in ...

Purpose: A review of the significant findings related to the use of the thiazolidinediones (TZDs) in the treatment of patients with type 2 diabetes mellitus and heart failure was conducted.

Thiazolidinediones (TZDs) are the major drug class used to improve insulin sensitivity in the treatment of type 2 diabetes. However, TZDs have several adverse effects, including weight gain and ...

Although these results are intriguing and certainly provide evidence for a subpopulation of NASH patients that do not appear to respond to therapy with the TZDs, this study is limited by the ...

Renal or hepatic impairment. Elderly. Pregnancy. Nursing mothers. Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs.

Renal or hepatic impairment. Elderly. Pregnancy. Nursing mothers. Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs.

Researchers have discovered the biochemical workings of an old-fashioned diabetes drug, and it's helping them develop new, safer alternatives.